Skip to main content

Table 2 Mean differences in daily steps and accelerometer wear time between baseline and 6 months and baseline and 12 months for each intervention group

From: Process evaluation of the Sophia Step Study- a primary care based three-armed randomized controlled trial using self-monitoring of steps with and without counseling in prediabetes and type 2 diabetes

  Multicomponent group A
Mean change
(95% CI) (n)
Single component group B
Mean change
(95% CI) (n)
Control Group C
Mean change
(95% CI) (n)
Daily steps
baseline- 6 months
941 (227, 1655) (n = 40) 990 (145, 1836) (n = 43) − 506 (− 1118, 107) (n = 37)
Wear time (min)
baseline- 6 months
12.6 (− 19.5, 44.8) (n = 40) 11.0 (−4.8, 26.8) (n = 43) 14.8 (−11.0, 40.6) (n = 37)
Daily steps
baseline- 12 months
31 (− 507, 570) (n = 46) 144 (−566, 853) (n = 39) −890 (− 1485, − 294) (n = 39)
Wear time (min)
baseline- 12 months
− 10.1 (− 29.3, 9.0) (n = 46) −0.7 (− 21.8, 20.1) (n = 39) 8.6 (− 14.2, 31.4) (n = 39)